| 05/31/18 |
NIH |
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
LOI due 30 days prior to the application due date |
| 05/31/18 |
NIH |
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) |
Link |
NIH |
Standard dates apply |
LOI due 30 days prior to the application due date |
| 05/31/18 |
NIH |
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) |
Link |
Research |
Standard due dates apply |
|
| 05/22/18 |
NIH |
The Role of Mobile Genetic Elements in Cancer (R01) |
Link |
Research |
Standard due dates apply |
|
| 05/22/18 |
NIH |
Metabolic Reprogramming to Improve Immunotherapy (R01) |
Link |
Research |
Standard due dates apply |
Standard due dates apply: Cycle II - June 5 |
| 05/22/18 |
NIH |
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) |
Link |
Research |
Standard due dates apply |
LOI due 30 days prior to the application due date |
| 05/11/18 |
NIH |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) |
Link |
NIH |
01/09/20 |
LOI Due 45 days prior to the application due date |
| 04/30/18 |
Hope Foundation |
SWOG Trial Support (STrS) |
Link |
Foundation |
|
|
